GFW drastically reduced the expression of MMP-2, MMP-9, and VEGF, indicating that GFW can inhibit the invasion, metastasis, and angiogenesis of AM lesions, which was consistent with the previous network pharmacology prediction results. This evidence concerns the gene MMP2 and acute myeloblastic leukemia with maturation.